![Shefali Agarwal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shefali Agarwal
President chez
VALERIO THERAPEUTICS
Fortune : 29 792 $ au 31/05/2026
Profil
Shefali Agarwal currently works at Sironax Ltd., as President, Chief Executive Officer & Director, Valour Bio SAS, as President & Chief Executive Officer, Fate Therapeutics, Inc., as Independent Director from 2019, ITB-MED AB, as Director, and Valerio Therapeutics SA, as President from 2024.
Dr. Agarwal also formerly worked at Nexoplex Bio, Inc., as Independent Director from 2021 to 2025, TopoTarget UK Ltd., as Director, SQZ Biotechnologies Co., as Chief Medical Officer from 2017 to 2018, and Epizyme, Inc., as Executive VP, Chief Medical & Development Officer from 2021 to 2022.
Dr. Agarwal received her graduate degree in 2003 from The Johns Hopkins University, doctorate degree in 2000 from Karnataka University, and graduate degree in 2002 from Merrick School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/06/2026 | 10 490 ( 0,01% ) | 29 792 $ | 31/05/2026 |
Postes actifs de Shefali Agarwal
| Sociétés | Poste | Début |
|---|---|---|
| FATE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/07/2019 |
| VALERIO THERAPEUTICS | President | 06/04/2022 |
Itbmed AB
 Itbmed AB Miscellaneous Commercial ServicesCommercial Services Engages in developing immunomodulatory biologics for organ transplantation | Directeur/Membre du Conseil | - |
Sironax Ltd.
 Sironax Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | - |
Anciens postes connus de Shefali Agarwal
| Sociétés | Poste | Fin |
|---|---|---|
| GRITSTONE BIO, INC. | Directeur/Membre du Conseil | 04/04/2025 |
| EPIZYME, INC. | Directeur Technique/Scientifique/R&D | 06/04/2022 |
| SQZ BIOTECHNOLOGIES COMPANY | Directeur Technique/Scientifique/R&D | 01/05/2018 |
TopoTarget UK Ltd.
 TopoTarget UK Ltd. Drugstore ChainsRetail Trade Develops anti-cancer drugs | Directeur/Membre du Conseil | - |
Formation de Shefali Agarwal
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
51
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
SQZ Biotechnologies Co.
 SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Valerio Therapeutics SA
 Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TopoTarget UK Ltd.
TopoTarget UK Ltd. Drugstore ChainsRetail Trade Develops anti-cancer drugs | Retail Trade |
Karnataka University
 Karnataka University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Merrick School of Business
 Merrick School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
Itbmed AB
Itbmed AB Miscellaneous Commercial ServicesCommercial Services Engages in developing immunomodulatory biologics for organ transplantation | Commercial Services |
Sironax Ltd.
Sironax Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
